Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset Seizures
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Sunita Misra, MD
SK Life Science, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- I. Sz. Gyermekgyógyászati Klinika
Budapest, Hungary
- Chungbuk National University Hospital
Cheonju, South Korea
- Seoul National University Hospital
Seoul, South Korea
- Severance Hospital
Seoul, South Korea
- Ajou University Hospital
Suwon, South Korea
- Phoenix Children'S Hospital
Phoenix, Arizona, United States
- Mid-Atlantic Epilepsy and Sleep Center
Bethesda, Maryland, United States
- Missouri University Pediatric and Adolescent Specialty Clinic
Columbia, Missouri, United States
- Northeast Regional Epilepsy Group
Hackensack, New Jersey, United States
- Duke University
Durham, North Carolina, United States
- Cincinnati Children'S Hospital
Cincinnati, Ohio, United States
- Le Bonheur Children'S Hospital
Memphis, Tennessee, United States
- Multicare Institute - Mary Bridge Children'S Neurology
Tacoma, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 27 May 2021
- Primary completion
- 6 Nov 2025
- Completion
- 6 Nov 2025
- Last update posted
- 31 Mar 2026
- Registered enrollment
- 26
- Registry id
- NCT04903314
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.